SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016848
Filing Date
2022-08-11
Accepted
2022-08-11 16:06:54
Documents
55
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dice-20220630.htm   iXBRL 10-Q 2872948
2 EX-4.1 dice-ex4_1.htm EX-4.1 159873
3 EX-10.1 dice-ex10_1.htm EX-10.1 181883
4 EX-31.1 dice-ex31_1.htm EX-31.1 19760
5 EX-31.2 dice-ex31_2.htm EX-31.2 19493
6 EX-32.1 dice-ex32_1.htm EX-32.1 12851
7 EX-32.2 dice-ex32_2.htm EX-32.2 12288
  Complete submission text file 0000950170-22-016848.txt   7778459

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dice-20220630_cal.xml EX-101.CAL 44888
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dice-20220630_pre.xml EX-101.PRE 225996
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dice-20220630.xsd EX-101.SCH 36557
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dice-20220630_def.xml EX-101.DEF 126455
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dice-20220630_lab.xml EX-101.LAB 329884
49 EXTRACTED XBRL INSTANCE DOCUMENT dice-20220630_htm.xml XML 1055512
Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40794 | Film No.: 221155698
SIC: 2834 Pharmaceutical Preparations